Her2 (ECD and Neu )

 

 

In about 1 of every 5 breast cancers, the cancer cells have a gene mutation that makes an excess of the HER2 protein. HER2-positive breast cancers tend to be more aggressive than other types of breast cancer.

Catalog# Product Description Product Type Size
200-530-HERHuman Her2/neu/Erbb2/CD340 protein ELISA kit, 96 testsELISA Kit1 Kit
200-600-HRHHuman Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Kit1 Kit
200-600-HRHHuman Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Kit1 Kit
200-610-HRMHuman Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Kit1 Kit
200-620-HRHMouse Anti-Her2 Protein (ECD) ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Kit1 Kit
200-630-HRMMouse Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Kit1 Kit
200-640-HRHHuman Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-650-HRMHuman Anti-Her2 vaccine (E75-peptide) IgM ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-660-HRHMouse Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-670-HRMMouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-700-HRHHuman Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-710-HRMHuman Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-720-HRHMouse Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-730-HRMMouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
HER2-369-AAnti-HER2 peptide IgG (cyclic 367-37; E75 vaccine candidate) Aff pureAntibodies100 ul
HER2-597-AAnti-HER2 peptide IgG (cyclic 597-626 vaccine candidate) Aff pureAntibodies100 u
HER21-MMouse Monoclonal anti-human Her2/neu(erbB-2) protein IgG, aff pureAntibodies100 ug
HER31-MRabbit mono anti-human Her2/Erbb2/Neu (1-652) protein IgGAntibodies 
HER32-AAnti-human Her2/Erbb2/Neu (1-652) protein IgGAntibodies100 ul
HER33-MMouse mono anti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgGAntibodies100 ul
HER34-AAnti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgGAntibodies100 ul
HER35-MHumanized anti-human Her2/Erbb2/Neu protein IgG (Herceptin Biosimilar)Antibodies100 ul
MA-20127Mouse Monoclonal Anti-Human Epidermal Growth Factor Receptor 2 (HER2)  
HER2-369-PHER2 peptide, (369 377), E75 vaccine candidatePeptide5 mg
HER2-563-PHER2 peptide, cyclic, (563-598, cys-cys disulphide bond); vaccine candidatePeptide5 mg
HER2-585-PHER2 peptide, cyclic, (585-598, cys-cys disulphide bond); vaccine candidatePeptide5 mg
HER2-597-PHER2 peptide, cyclic, (597-626, cys-cys disulphide bond) vaccine candidatePeptide5 mg
HER2-654-PHER2 peptide, (654 662), GP2 vaccine candidatePeptide5 mg
HER2-776-PHER2 peptide, (776 790 fused with LRMK, C-Term ), GP2 vaccine candidatePeptide5 mg
HER2-MP1HER2 multi peptide, (369-386, 688-703,971-984); vaccine candidatePeptide5 mg
HER2-MP2HER2 multi peptide, (776-790,927-941,1116-1180); vaccine candidatePeptide5 mg
HER2-MP3HER2 multi peptide, (42-56,98-114,328-345); vaccine candidatePeptide5 mg
SP-51177-1HER2/neu (869-877) peptide [Leu-Leu-Asp-Ile-Asp-Glu-Thr-Glu-Tyr-OH; MW: 1110.19]Pure Peptide1 mg
SP-52260-1HER2/neu(654-662) GP2 [H-Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu-OH; MW: 884.12]Pure Peptide1 mg
HER24-R-10Recombinant (HEK) mouse Her2/Erbb2/Neu (23-653)-his tag fusion proteinPure Protein10 ug
HER25-R-20Recombinant (E.Coli) Her2/neu(erbB-2) Herstatin protein, purifiedPure Protein20 ug
HER26-R-10Recombinant (HEK) mouse Her2/Erbb2/Neu (1-653)-hIgG1-Fc fusion proteinPure Protein10 ug
HER265-R-10Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-his tag fusion proteinPure Protein10 ug
HER29-R-10Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-his tag fusion proteinPure Protein10 ug
HER30-R-10Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-hIgG1-Fc fusion protein 10 ug
HER21-R-10Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-hIgG-Fc fusion protein 10 ug
HER22-R-5Recombinant (sf9) human Her2/Erbb2/Neu (676-1255)-GST fusion proteinProtein5 ug
HER23-R-10Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-his tag fusion proteinProtein10 ug
HER266-R-10Recombinant (HEK) Human Her2/Erbb2/Neu (676?1255, intracellular domain) GST TagProtein10 ug
HER27-R-10HER2/ErB2 recombinant protein (1-652, extracellular domain), Human (E. coli)Protein10 ug
HER28-R-10Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-hIgG1-Fc fusion proteinProtein10 ug
HER36-R-10Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-Flag tag (DDDDK) fusion proteinProtein10 ug
HER36-R-50Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-Flag tag (DDDDK) fusion proteinProtein50 ug
HER21-CRecombinant human Her2/neu(erbB-2)-Fc protein control for WBWestern control100 ul
RDT-14000-HERTruStrip RDT Her2 Protein Rapid test cards,25/pkRapid Test1pk
SM-101000-5EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992Chemical5 mg
SM-101000-50EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992Chemical50 mg
SM-101010-5Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%)Chemical5 mg
SM-101010-50Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%)Chemical50 mg
SM-101010-50Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%)Chemical50 mg
SM-101020-10Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%)Chemical10 mg
SM-101020-50Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%)Chemical50 mg
SM-101030-100Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%)Chemical100 mg
SM-101030-25Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%)Chemical25 mg
SM-101040-25Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%)Chemical25 mg
SM-101040-5Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%)Chemical5 mg
SM-101050-10Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%)Chemical10 mg
SM-101050-100Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%)Chemical100 mg
SM-101060-100Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%)Chemical100 mg
SM-101060-25Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%)Chemical25 mg
SM-101070-10Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%)Chemical10 mg
SM-101070-50Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%)Chemical50 mg
SM-101080-25CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%)Chemical25 mg
SM-101080-5CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%)Chemical5 mg
SM-101090-25AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%)Chemical5 mg
SM-101090-5AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%)Chemical5 mg
SM-101100-25AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%)Chemical25 mg
SM-101100-5AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%)Chemical5 mg
SM-101110-10Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%)Chemical10 mg
SM-101110-50Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%)Chemical50 mg
SM-101120-25Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%)Chemical25 mg
SM-101120-5Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%)Chemical5 mg
SM-101130-25Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%)Chemical25 mg
SM-101130-5Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%)Chemical5 mg
200-510-RDTTruStrip RDT Herceptin/Trastuzumab (anti-Her2) Rapid Test cards, 10/pkRapid Test1 pk
200-530-RDTTruStrip RDT Her2 Protein Rapid test cards, 10/pkRapid Test1 Pk
200-600-01NHuman Anti-Her2 Protein (ECD domain) IgG negative control serumSerum Controls1 ml
200-600-02PHuman Anti-Her2 Protein (ECD domain) IgG positive control serumSerum Controls1 ml
HER2-613-PHER2 peptide, cyclic, (613-626, cys-cys disulphide bond); vaccine candidatepeptide5 mg
HER25-R-100Recombinant (E. Coli) Her2/neu(erbB-2) Herstatin protein, purifiedPure Protein100 ug
200-530-HERHuman Her2/neu/Erbb2/CD340 protein ELISA kit, 96 tests, quantitativeELISA Kit1 kit
200-600-HRHHuman Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Kit1 Kit
200-610-HRMHuman Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Kit1 Kit
200-620-HRHMouse Anti-Her2 Protein (ECD) ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Ki 
200-630-HRMMouse Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, QuantitativeELISA Kit1 Kit
200-640-HRHHuman Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-650-HRMHuman Anti-Her2 vaccine (E75-peptide) IgM ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-660-HRHMouse Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, QuantitativeELISA Kit 
200-670-HRMMouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, QuantitativeELISA Kit1 Kit
200-700-HRHHuman Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, QuantitativeELISA Kit 
200-710-HRMHuman Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, QuantitativeELISA Kit 
200-720-HRHMouse Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, QuantitativeELISA Kit 
200-730-HRMMouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, QuantitativeELISA Kit 
AR-237-UHER3 (A30), RNA Aptamer, unlabeledRNA Aptamers 
HER2-369-AAnti-HER2 peptide IgG (cyclic 367-37; E75 vaccine candidate) Aff pureAntibodies100 ul
HER2-369-PHER2 peptide, (369 ?377), E75 vaccine candidatepeptide5 mg
HER2-563-PHER2 peptide, cyclic, (563-598, cys-cys disulphide bond); vaccine candidatepeptide5 mg
HER2-585-PHER2 peptide, cyclic, (585-598, cys-cys disulphide bond); vaccine candidatepeptide5 mg
HER2-597-AAnti-HER2 peptide IgG (cyclic 597-626 vaccine candidate) Aff pureAntibodies100 u
HER2-597-PHER2 peptide, cyclic, (597-626, cys-cys disulphide bond) vaccine candidatepeptide5 mg
HER2-776-PHER2 peptide, (776 ? 790 fused with LRMK, C-Term ), GP2 vaccine candidatepeptide5 mg
HER2-MP1HER2 multi peptide, (369-386, 688-703,971-984); vaccine candidatepeptide5 mg
HER2-MP2HER2 multi peptide, (776-790,927-941,1116-1180); vaccine candidatepeptide5 mg
HER2-MP3HER2 multi peptide, (42-56,98-114,328-345); vaccine candidatepeptide5 mg
HER21-CRecombinant human Her2/neu(erbB-2)-Fc protein control for WBWestern control100 ul
HER21-MMouse Monoclonal anti-human Her2/neu(erbB-2) protein IgG, aff pureAntibodies100 ug
HER21-R-10Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-hIgG-Fc fusion proteinRec. Protein10 ug
HER22-R-5Recombinant (sf9) human Her2/Erbb2/Neu (676-1255)-GST fusion proteinRec. Protein5 ug
HER23-R-10Recombinant (HEK) human Her2/Erbb2/Neu (23-652)-his tag fusion proteinRec. Protein10 ug
HER24-R-10Recombinant (HEK) mouse Her2/Erbb2/Neu (23-653)-his tag fusion proteinRec. Protein10 ug
HER25-R-20Recombinant (E.Coli) Her2/neu(erbB-2) Herstatin protein, purifiedRec. Protein20 ug
HER26-R-10Recombinant (HEK) mouse Her2/Erbb2/Neu (1-653)-hIgG1-Fc fusion proteinRec. Protein10 ug
HER265-R-10Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-his tag fusion proteinRec. Protein10 ug
HER266-R-10Recombinant (HEK) Human Her2/Erbb2/Neu (676?1255, intracellular domain) GST TagRec. Protein10 ug
HER27-R-10Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-his tag fusion proteinRec. Protein10 ug
HER28-R-10Recombinant (HEK) rat Her2/Erbb2/Neu (4-656)-hIgG1-Fc fusion proteinRec. Protein10 ug
HER29-R-10Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-his tag fusion proteinRec. Protein10 ug
HER30-R-10Recombinant (HEK) monkey/rhesus Her2/Erbb2/Neu (1-652)-hIgG1-Fc fusion proteinRec. Protein10 ug
HER31-MRabbit mono anti-human Her2/Erbb2/Neu (1-652) protein IgGAntibodies100 ul
HER32-AAnti-human Her2/Erbb2/Neu (1-652) protein IgGAntibodies100 ul
HER33-MMouse mono anti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgGAntibodies100 ul
HER34-AAnti-monkey/rhesus Her2/Erbb2/Neu (1-652) protein IgGAntibodies100 ul
HER35-MHumanized anti-human Her2/Erbb2/Neu protein IgG (Herceptin Biosimilar)Primary Antibodies100 ul
HER36-R-10Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-Flag tag (DDDDK) fusion proteinRec. Protein10 ug
HER36-R-50Recombinant (HEK) human Her2/Erbb2/Neu (1-652)-Flag tag (DDDDK) fusion proteinRec. Protein50 ug
SM-101000-5EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992Chemical5 mg
SM-101000-50EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992Chemical50 mg
SM-101010-5Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%)Chemical5 mg
SM-101010-50Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%)Chemical50 mg
SM-101020-10Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%)Chemical10 mg
SM-101020-50Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%)Chemical50 mg
SM-101030-100Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%)Chemical100 mg
SM-101030-25Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%)Chemical25 mg
SM-101040-25Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%)Chemical25 mg
SM-101040-5Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%)Chemical5 mg
SM-101050-10Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%)Chemical10 mg
SM-101050-100Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%)Chemical100 mg
SM-101060-100Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%)Chemical100 mg
SM-101060-25Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%)Chemical25 mg
SM-101070-10Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%)Chemical10 mg
SM-101070-50Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%)Chemical50 mg
SM-101080-25CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%)Chemical25 mg
SM-101080-5CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%)Chemical5 mg
SM-101090-25AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%)Chemical25 mg
SM-101090-5AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%)Chemical5 mg
SM-101100-25AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%)Chemical25 mg
SM-101100-5AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%)Chemical5 mg
SM-101110-10Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%)Chemical10 mg
SM-101110-50Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%)Chemical50 mg
SM-101120-25Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%)Chemical25 mg
SM-101120-5Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%)Chemical5 mg
SM-101130-25Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%)Chemical25 mg
SM-101130-5Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%)Chemical5 mg
SP-51177-1HER2/neu (869-877) peptide [Leu-Leu-Asp-Ile-Asp-Glu-Thr-Glu-Tyr-OH; MW: 1110.19]Pure Peptide1 mg
SP-52260-1HER2/neu(654-662) GP2 [H-Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu-OH; MW: 884.12]Pure Peptide1 mg
200-341-ULRemicade (Infliximab/Infimab/Remsima/Inflectra) for ELISAELISA Kit100 ug
200-340-CUXCustom Testing of Samples for Remicade (Infliximab/Infimab/Remsima/Inflectra) by ELISACustom Service1
210-200-CUXCustom Testing of Samples for Ipilimumab (Yervoy/MDX-010/MDX-101) by ELISACustom Service1
200-410-CUXCustom Testing of Samples for Xolair/Omalizumab by ELISACustom Service1
200-410-XLGXolair/Omalizumab ELISA Kit for human, 96 tests, QuantitativeELISA Kit1 Kit
200-510-CUXCustom Testing of Samples for Herceptin/Trastuzumab by ELISA 1
210-400-CUXCustom Testing of Samples for Eculizumab (Soliris) by ELISACustom Service1
220-250-CUXCustom Testing of Samples for Mertansine (Free or conjugated) Drug by ELISACustom Service1
210-100-CUXCustom Testing of Samples for Erbitux (Cetuximab/C225/IMC225) by ELISACustom Service1
200-210-CUXCustom Testing of samples for Rituximab/Rituxan ELISA KitCustom Service1
200-310-CUXCustom Testing of Samples for Humira/Adalimumab by ELISACustom Service1
210-320-CUXCustom Testing of Samples for Basiliximab (Simulect) by ELISACustom Service1
200-360-CUXCustom Testing of Samples for Aflibercept/Eylea by ELISACustom Service1
200-800-CUXCustom Testing of Samples for Avastin/Bevacizumab (Anti-VEGF) by ELISACustom Service1
200-880-CUXCustom Testing of Samples for Lucentis/Ranibizumab by ELISACustom Service1
200-880-S1000Lucentis/Ranibizumab ELISA Standard (1000 ng/ml) for use ELISAStandard1 ml
PLGF15-R-25Recombinant (E. coli) human placenta growth factor-1 (PLGF-1) Protein (>97%), biologically active 25 ug
PLGF15-R-5Recombinant (E. coli) human placenta growth factor-1 (PLGF-1) Protein (>97%), biologically active 5 ug
VEGF28-R-10Human Recombinant VEGF121 Protein (E. coli, his-tag)Rec. Protein10 ug
AB-23085-ARabbit Anti-Human Tyrosine-protein kinase receptor UFO (Axl) (AXL- phosphor) IgG (aff pure)Primary Antibodies100ug
AB-23085-CPHuman Tyrosine-protein kinase receptor UFO (Axl) control (non-phosphor) peptide 100ug
AB-23085-PHuman Tyrosine-protein kinase receptor UFO (Axl) control (AXL- phosphor) peptide 100ug
AR-302-UReceptor Tyrosine Kinase (RET) Mutant (D4), RNA Aptamer, unlabeledRNA AptamersCustom
RP-747Recombinant (E.Coli) Human Tyrosine Kinase ErbB-3Pure protein5 ug
RP-748Recombinant (E.Coli, his tag) Human Tyrosine Kinase ErbB-2Pure protein5 ug
SP-101378-1Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Acetylated, Amide, Phosphorylated (AA: Ac-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-pTyr-Ala-Ala-Arg-Gly-NH2) (MW: 1640.75)Pure Peptide1 mg
SP-101401-1Tyrosine Protein Kinase JAK 2 (AA: Val-Leu-Pro-Gln-Asp-Lys-Glu-pTyr-pTyr-Lys-Val-Lys-Glu-Pro-Gly-Glu) (MW: 2082.18)Pure Peptide1 mg
SP-101516-5pp60(v-SRC) Autophosphorylation Site, Protein Tyrosine Kinase Substrate (AA: Arg-Arg-Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gly) (MW: 1592.74)Pure Peptide5 mg
SP-101518-5Biotin-RR-SRC, Insulin Receptor Tyrosine Kinase Substrate (AA: Biotin -Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly) (MW: 1745.99)Pure Peptide5 mg
SP-86883-1Biotin-Tyrosine Kinase Peptide 1, amide (AA: Biotin-Lys-Val-Glu-Lys-Ile-Gly-Glu-Gly-Thr-Tyr-Gly-Val-Val-Tyr-Lys-NH2) (MW: 1895.27)Pure Peptide1 mg
MCD200R-BAnti-Mouse CD200R, Biotin (Clone OX110) (rat IgG2a)Antibodies100 tests
MCD200R-FAnti-Mouse CD200R, FITC (Clone OX110) (rat IgG2a)Antibodies50 Tests
MCD200R-MAnti-Mouse CD200R, Purified (Clone OX110) (rat IgG2a)Primary Antibodies100 ug
MCD200R-PEAnti-Mouse CD200R, PE (Clone OX110) (rat IgG2a)Antibodies50 tests
ERB21-AAnti-Rat Estrogen Receptor-beta 2 (ER-b) IgG #1, aff purePrimary Antibodies100 ug
ERB21-PRat Estrogen Receptor-beta 2 (ER-b) Control/blocking peptide #1Peptide100 ug
ERB21-SAnti-Rat Estrogen Receptor-beta 2 (ER-b) antiserum #1Primary Antibodies100 ul
ERB22-MMouse Monoclonal Anti-Human Estrogen Receptor-beta (ER-beat) protein IgGPrimary Antibodies100 ul
CTLA45-R-25Recombinant (HEK) Human CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4/CD152) protein (37-162aa, >95%, his-tag, low endotoxin) 25 ug
CTLA46-R-25Recombinant (HEK) Mouse CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4/CD152) protein (36-162aa, >95%, his-tag, low endotoxin) 25 ug
100-205-TNRRat TNF-alpha ELISA Kit, High Sensitivity, 96 tests, Quantitative 1 kit